Carafate Suspension Articles

Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid

20 October 2009

Fujisawa makes strategic drug transfers ahead of merger

28 February 2005

Aventis sells off three drugs for $145 million

13 October 2003

Good start for Merck KGaA generics in Italy

5 December 2001

Chugai shares downgraded on concerns over product pipeline

6 September 2000

Chugai reports recent filings and R&D pipeline

2 August 1999

Chugai moving into France and Germany

24 February 1999

Chugai Restructures For The 21st Century

28 August 1998

Teva's Strength: Coping With Change

21 July 1997

1996 A Year Of M&As For Teva Pharmaceuticals

3 March 1997

Searle Reports Progress With COX-2 Inhibitor

21 October 1996

Teva's Copaxone "Approvable" In USA

14 October 1996

Mixed Results For Smaller US Firms In First Qtr

8 May 1995

Surge In Profits At Chugai Pharmaceutical

3 April 1995

Hoechst Offers $7 Billion For Marion Merrell Dow

6 March 1995

DOW CHEM MAY SELL ITS MMD STAKE

27 June 1994

US CHEMICAL/DRUG COs SHOW 1st QTR GROWTH

9 May 1994

US 3rd QTR RESULTS MIXED AS DRUG IND CUTS BACK

25 October 1993

MARION MERRELL/ NOVOPHARM PACT

13 September 1993

MISOPROSTOL PRAISED AT ILAR

26 July 1993

DELISTING AND OTC SALES IN DENMARK

26 July 1993

MERCK AG AN OVERVIEW OF 1992 PERFORMANCE

19 July 1993

OTC GASTROINTESTINALS IN THE USA

24 May 1993

GLAXO AND LILLY'S ULCER DRUGS OFF MEDI-CAL

18 January 1993

GOOD SALES GROWTH FOR MAJOR US COS IN 1st QTR

27 April 1992

EC PHARMA MARKET LURCHES TO COMPLETION

20 April 1992

1991 A "SUPERB" YEAR FOR MARION MERRELL DOW

13 April 1992

BIOCRAFT BOOSTED BY APPROVALS

13 April 1992

FDA MOVE UPGRADES BIOCRAFT EARNINGS

9 March 1992

US GENERIC DRUG MARKET TO 1995

17 February 1992

Showing 1-30 of 30 articles

Go to beginningPrevious
  • 1
NextGo to end